Device Trial Radar · NCT03720171
e-OPRA Implant System for Lower Limb Amputees
Last checked: Nov 19, 2026Latest source record: May 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2
Actual
Start
Jan 17, 2018
Primary completion
Mar 8, 2025
Study completion Mar 8, 2025
Sponsor
- Lead sponsor
- IntegrumNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Brigham and Women's Hospital; Massachusetts Institute of Technology
- First posted
- Oct 25, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The e-OPRA Implant System, is a further development of the OPRA (Osseointegrated Prostheses for the Rehabilitation of Amputees) Implant System, approved under HDE (Humanitarian Device Exemption) H080004. The e-OPRA Implant system is an implant system for direct skeletal anchorage of amputation prostheses. The added feature in the e-OPRA Implant system, is a bidirectional interface into the human body that allows permanent and reliable communication using implanted electrodes. These electrodes will provide long-term stable bioelectric signals for an improved control of the prosthetic limb. The purpose of the study is to evaluate the feasibility of a lower limb amputee with the e-OPRA Implant System exhibiting full neural control over a neuro-mechanical prosthetic system. A maximum of six subjects will be enrolled. Each subject will undergo a surgery where the e-OPRA Implant System will be implanted. The subjects will participate in follow-up sessions of which the last one occurs approximately 24 months after the surgery. This is a prospective, non-randomized, uncontrolled study.
Conditions
- Amputation
Interventions
e-OPRA Implant SystemDevice
Implantation of e-OPRA Implant System in lower limb to be used with amputation limb prosthesis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Electrode functionTime frame: 24 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
MIT Media Lab
Cambridge, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.